StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Hey, can either of you two boneheads

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 12, 2021 12:51am

78 Views

Post# 32549355

RE:RE:RE:RE:RE:Hey, can either of you two boneheads

Q1 is may 15th, only 2 months away:)

Jonnyboy85 wrote: Did you know Q4 revenue reporting is coming March 31st? 6 weeks away
Jonnyboy85 wrote: You two ever heard of China? Barbados? Szls has:)
Jonnyboy85 wrote: Don't suppose either of you two know of a certain groundbreaking technology that our company is launching in the next 6 weeks? I'll give you a hint it starts with an A and rhymes with go fk yourself
Jonnyboy85 wrote: How about how many new partners we've added in 2020??
Jonnyboy85 wrote: Tell me how much revenue we made last quarter??